Staphylococcus aureus vaccine against mastitis in dairy cows,composition and evaluation of its immunogenicity in a mouse model |
| |
| Authors: | Leitner G Lubashevsky E Trainin Z |
| |
| Institution: | National Mastitis Reference Center, Ministry of Agriculture and Rural Development, PO Box 12, Bet Dagan 50250, Israel. leitnerg@int.gov.il |
| |
| Abstract: | Bovine mastitis caused by Staphylococcus aureus (S. aureus) is a most important infection disease that affects both the quality and the quantity of milk production. Antibiotic therapies formulated for intramammary use are generally unsuccessful in eliminating existing S. aureus infections. Vaccination is a logical approach to the control of S. aureus udder infections. However, to date commercially available S. aureus vaccine have shown limited efficacy under field conditions, mainly due to the paucity of information regarding relevant antigens which will induce a broad spectrum immunization. In the present paper the attempt to develop a new vaccine designated MASTIVAC I is described. MASTIVAC I is composed of three strains of S. aureus namely: VLVL8407; ZO3984 and BS449 which were isolated from clinical and sub-clinical cases of bovine mastitis. A mouse model was used to evaluate the S. aureus specific antibody production and protection of mice against virulent S. aureus strains. The results obtained showed that this vaccine exhibits a broad spectrum of antigenic and immunogenic properties that protects mice from homologues and hetrologous S. aureus challenge. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
